Cann Group Limited (CNGGF)
OTC PINK OTC PINK Primary Summary
CNGGF Chart
Cann Group Limited (CNGGF) Shareholder/Analyst Call Transcript
Cann Group Limited (OTCPK:CNGGF) Shareholder/Analyst Call November 4, 2025 6:15 PM EST Company Participants Jennifer Pilcher - CEO, MD & Executive Director Mike Ryan Presentation Jennifer Pilcher CEO, MD & Executive Director All right. Welcome to today's webinar, everybody.
Cann American Corp. Provides Shareholder Update
Company Announces Launch of Prodigy Health Plus ORLANDO, FL / ACCESSWIRE / July 9, 2024 / Cann America Corp. (OTC PINK:CNNA), the "Company", and the parent company of subsidiaries, Prodigy Health Plus and Prodigy Stem Cell (collectively known as "Prodigy Elite Group"), is excited to announce the official launch of Prodigy Health Plus, a crucial component of its comprehensive suite of healthcare products. The launch marks the beginning of a series of product releases.
Cann Group Limited (CNGGF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
When is the next earnings date?
Has Cann Group Limited ever had a stock split?
Cann Group Limited Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Ms. Jennifer Lee Pilcher AGIA, BBS, C.A. CEO | OTC PINK Exchange | AU000000CAN2 ISIN |
| AU Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Cann Group Limited is a pioneering company that specializes in the breeding, cultivation, production, manufacturing, supplying, and selling of medicinal cannabis. Founded in the year 2014, it has carved a niche for itself in the medicinal cannabis industry. The company boasts licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. Headquartered in Port Melbourne, Australia, Cann Group Limited stands at the forefront of the medicinal cannabis sector, contributing significantly to research and development in this evolving field.
Products and Services
- Medicinal Cannabis Cultivation:
Cann Group Limited focuses on the breeding and cultivation of cannabis strains specifically tailored for medicinal purposes. Their cultivation practices are designed to produce high-quality cannabis plants that meet the stringent requirements of medicinal cannabis products.
- Production and Manufacturing:
In addition to cultivation, the company is involved in the production and manufacturing of medicinal cannabis. This includes the extraction of active pharmaceutical ingredients (APIs) and the creation of various medicinal cannabis products that adhere to pharmacological standards.
- Supplying and Selling Medicinal Cannabis:
Cann Group Limited is also engaged in the supplying and selling of medicinal cannabis, making their high-quality products available to patients in need. Their comprehensive supply chain ensures that medicinal cannabis reaches patients through legal and regulated channels.
- Research and Development:
With a license to undertake research, Cann Group Limited is deeply invested in advancing the scientific understanding of cannabis for medicinal use. Their research efforts aim to innovate and enhance the effectiveness, safety, and accessibility of medicinal cannabis treatments.
Contact Information
